Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03713710 · ClinicalTrials.gov registry record · NA
Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta
A NA study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- NA
- Development phase
- 335
- Enrollment target
NCT03713710 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 335 participants.
The verdict
NCT03713710, a NA study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 335 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the efficacy and costs of this patient-centered approach ("Choice" between two cervical cancer screening modalities) in adherence to cervical cancer screening as compared to the current standard of care within the public health system in Mississippi (Pap test at the local department -"Pap") among un/under-screened African American women in the Mississippi Delta using a theory-based, culturally relevant intervention implemented by Peer Health Educators (PHEs).
Interventions
- BEHAVIORAL Choice
- BEHAVIORAL Pap testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 335 participants |
| Start Date | 2016-11-28 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03713710
The ClinicalTrials.gov registry entry for NCT03713710 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 335 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Choice is the first listed.
NCT03713710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03713710 about?
NCT03713710 is a clinical study titled "Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta". The purpose of this study is to examine the efficacy and costs of this patient-centered approach ("Choice" between two cervical cancer screening modalities) in adherence to cervical cancer screening as compared to the current standard of care within the public health system in Mississippi (Pap test ...
What is the current status of trial NCT03713710?
This trial is currently completed. It is a NA study. The enrollment target is 335 participants. The study started on 2016-11-28. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT03713710?
The interventions under investigation include: Choice (BEHAVIORAL), Pap testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT03713710?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.